Kevin C. Bylund

Kevin C. Bylund, M.D. is an Associate Professor in the Department of Radiation Oncology at the University of Rochester School of Medicine and Dentistry. He practices at Wilmot Cancer Center and Highland Hospital, specializing in radiation oncology with clinical focus on genitourinary and gynecologic cancers. Affiliated with the University of Rochester Medical Faculty Group and Accountable Health Partners, he actively treats patients with prostate, bladder, kidney, testicular, endometrial, and cervical cancers.

Dr. Bylund's research centers on brachytherapy (both low-dose and high-dose rates), radiation therapy techniques, and protection of normal tissues during cancer treatment. His clinical interests include prostate cancer radiotherapy, gynecologic malignancies, and minimizing radiation side effects. His work demonstrates strong emphasis on adaptive radiotherapy, image-guided treatment planning, and managing radiation-induced complications.

His recent publications (2020-2025) reveal dominant trends in

• Advanced brachytherapy techniques for prostate and gynecologic cancers
• Analysis of radiation toxicity and protective pharmacological interventions
• Innovations in cone beam CT-guided adaptive radiotherapy
• Metastatic patterns in prostate cancer

with significant contributions to clinical trial methodology and radiation safety protocols.

Scientific recognition includes:

• Educator of the Year (2015)
• RSNA Roentgen Resident/Fellow Research Award (2012)
• RSNA Roentgen Resident/Fellow Research Award (2008)

As lead researcher for the PREDICT-RT* clinical trial (Parallel Phase III Randomized Trials for High Risk Prostate Cancer), Dr. Bylund directs significant grant-funded research investigating genomic risk-based treatment intensification/de-escalation. His educational contributions include systematic reviews on communication skills training for medical residents. Patient testimonials consistently highlight his compassionate communication style, technical expertise, and patient-centered approach to complex cancer treatment decisions.